Correlation Between OncoVista Innovative and Polydex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both OncoVista Innovative and Polydex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoVista Innovative and Polydex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoVista Innovative Therapies and Polydex Pharmaceuticals, you can compare the effects of market volatilities on OncoVista Innovative and Polydex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoVista Innovative with a short position of Polydex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoVista Innovative and Polydex Pharmaceuticals.
Diversification Opportunities for OncoVista Innovative and Polydex Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between OncoVista and Polydex is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OncoVista Innovative Therapies and Polydex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Polydex Pharmaceuticals and OncoVista Innovative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoVista Innovative Therapies are associated (or correlated) with Polydex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Polydex Pharmaceuticals has no effect on the direction of OncoVista Innovative i.e., OncoVista Innovative and Polydex Pharmaceuticals go up and down completely randomly.
Pair Corralation between OncoVista Innovative and Polydex Pharmaceuticals
Given the investment horizon of 90 days OncoVista Innovative is expected to generate 4.63 times less return on investment than Polydex Pharmaceuticals. But when comparing it to its historical volatility, OncoVista Innovative Therapies is 2.34 times less risky than Polydex Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Polydex Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 65.00 in Polydex Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 131.00 from holding Polydex Pharmaceuticals or generate 201.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.54% |
| Values | Daily Returns |
OncoVista Innovative Therapies vs. Polydex Pharmaceuticals
Performance |
| Timeline |
| OncoVista Innovative |
| Polydex Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
OncoVista Innovative and Polydex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OncoVista Innovative and Polydex Pharmaceuticals
The main advantage of trading using opposite OncoVista Innovative and Polydex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoVista Innovative position performs unexpectedly, Polydex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Polydex Pharmaceuticals will offset losses from the drop in Polydex Pharmaceuticals' long position.| OncoVista Innovative vs. Cyclacel Pharmaceuticals | OncoVista Innovative vs. Amylyx Pharmaceuticals | OncoVista Innovative vs. Axsome Therapeutics | OncoVista Innovative vs. Exelixis |
| Polydex Pharmaceuticals vs. ImmuCell | Polydex Pharmaceuticals vs. Senstar Technologies | Polydex Pharmaceuticals vs. Natural Alternatives International | Polydex Pharmaceuticals vs. Paragon Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |